Jounce Therapeutics, Inc. (JNCE) surged 55.58% last day. The drug maker entered into an exclusive agreement with Gilead Sciences, Inc. for a drug development program.
Akcea Therapeutics, Inc. (AKCA) on Monday announced signing an acquisition agreement with Ionis Pharmaceuticals, Inc. (IONS). The news caused its share price to surge on
Hancock Jaffe Laboratories, Inc. (HJLI) took a -7.32% dip on Wednesday after gaining 11.39% in Tuesday trading. The stock surged on the day when progress was